Globus Medical (GMED)
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
$78.29+0.22%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · GMED
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||
| Revenues | 3,144.9 | 2,938.9 | 2,519.4 | 1,568.5 | 1,022.8 | 958.1 | 789.0 | 785.4 | 713.0 | 636.0 | 564.0 | 544.8 | 474.4 | 434.5 | 386.0 |
| Total Revenues | 3,144.9 | 2,938.9 | 2,519.4 | 1,568.5 | 1,022.8 | 958.1 | 789.0 | 785.4 | 713.0 | 636.0 | 564.0 | 544.8 | 474.4 | 434.5 | 386.0 |
| Cost of Revenues | 989.1 | 957.8 | 1,035.5 | 548.2 | 263.7 | 239.2 | 217.5 | 180.0 | 159.4 | — | — | — | — | — | — |
| Gross Profit | — | — | — | 1,020.3 | 759.1 | 718.9 | 571.6 | 605.4 | 553.6 | 485.5 | 429.3 | 412.4 | 363.6 | 334.1 | 310.8 |
| Operating Expenses & Income | |||||||||||||||
| Selling, General & Admin | 1,216.7 | 1,178.5 | 981.0 | 643.8 | 432.1 | 408.1 | 354.8 | 354.8 | 311.6 | 267.8 | 222.2 | 210.2 | 188.6 | 182.5 | 168.9 |
| R&D Expenses | 147.1 | 147.2 | 163.8 | 124.0 | 73.0 | 97.3 | 84.5 | 60.1 | 55.5 | 43.7 | 44.5 | 36.3 | 31.2 | 26.9 | 27.9 |
| Operating Income | 639.5 | 479.8 | 166.0 | 133.1 | 228.0 | 172.0 | 111.4 | 172.0 | 169.3 | 161.8 | 154.1 | 172.2 | 138.4 | 101.7 | 114.8 |
| Earnings from Continuing Operations | |||||||||||||||
| Other Non-Operating Income / Expenses | 20.6 | 125.3 | (45.3) | 32.3 | 15.1 | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 660.1 | 605.1 | 120.7 | 165.4 | 243.0 | 180.4 | 125.9 | 189.9 | 188.6 | 169.9 | 157.3 | 172.8 | 138.6 | 102.0 | 114.7 |
| Income Tax Expense | 124.7 | 67.2 | 17.7 | 42.5 | 52.9 | 31.2 | 23.6 | 34.7 | 32.1 | 62.6 | 52.9 | 60.0 | 46.2 | 33.4 | 40.8 |
| Net Income | |||||||||||||||
| Net Income | 535.4 | 537.9 | 103.0 | 122.9 | 190.2 | 149.2 | 102.3 | 155.2 | 156.5 | 107.3 | 104.3 | 112.8 | 92.5 | 68.6 | 73.8 |
| Per Share | |||||||||||||||
| Basic EPS | 3.96 | 3.98 | 0.76 | 1.09 | 1.89 | 1.48 | 1.04 | 1.57 | 1.60 | 1.12 | 1.09 | 1.19 | 0.98 | 0.74 | 0.82 |
| Diluted EPS | 3.90 | 3.92 | 0.75 | 1.07 | 1.85 | 1.44 | 1.01 | 1.52 | 1.54 | 1.10 | 1.08 | 1.17 | 0.97 | 0.73 | 0.80 |
| Revenue per Share | 22.89 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 135.1 | 135.2 | 135.7 | 113.1 | 100.5 | 100.7 | 98.6 | 99.2 | 97.9 | 96.2 | 95.6 | 95.0 | 94.2 | 92.6 | 89.6 |
| Diluted Weighted Avg Shares | 137.4 | 137.1 | 137.9 | 114.6 | 102.6 | 103.6 | 101.0 | 102.0 | 101.3 | 97.9 | 96.4 | 96.1 | 95.5 | 94.2 | 92.2 |
| Supplemental | |||||||||||||||
| EBITDA | — | 756.7 | 420.0 | 278.7 | 296.2 | 241.8 | 174.3 | 224.7 | 211.0 | 203.9 | 192.9 | 196.3 | 160.1 | 121.1 | 132.9 |
| EBIT | 639.5 | 479.8 | 166.0 | 133.1 | 228.0 | 172.0 | 111.4 | 172.0 | 169.3 | 161.8 | 154.1 | 172.2 | 138.4 | 101.7 | 114.8 |
| Effective Tax Rate | 18.9% | — | — | 25.7% | 21.7% | 17.3% | 18.8% | 18.3% | 17.0% | 36.8% | 33.7% | 34.7% | 33.3% | 32.7% | 35.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.